ARK Investment Management - VERVE THERAPEUTICS INC ownership

VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of VERVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$68,959,525
-28.6%
5,200,567
+1.0%
0.53%
-17.4%
Q2 2023$96,578,455
+49.4%
5,150,851
+14.9%
0.64%
+43.9%
Q1 2023$64,631,752
-23.5%
4,482,091
+2.7%
0.44%
-39.3%
Q4 2022$84,478,811
-27.5%
4,365,830
+28.6%
0.73%
-10.0%
Q3 2022$116,579,000
+278.0%
3,393,859
+66.8%
0.81%
+346.7%
Q2 2022$30,837,000
-19.9%
2,034,124
+20.6%
0.18%
+13.0%
Q1 2022$38,496,000
-25.4%
1,686,945
+20.5%
0.16%
+3.2%
Q4 2021$51,601,000
-13.4%
1,399,545
+10.4%
0.16%
+9.1%
Q3 2021$59,582,000
+80.3%
1,267,705
+131.2%
0.14%
+134.4%
Q2 2021$33,040,000548,3890.06%
Other shareholders
VERVE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,508,809$57,251,0008.18%
Alphabet Inc. 10,974,011$250,427,0008.12%
M28 Capital Management LP 178,500$4,073,0003.74%
Casdin Capital, LLC 3,138,167$71,613,0003.21%
Ally Bridge Group (NY) LLC 105,360$2,404,0001.78%
Redmile Group, LLC 1,835,328$41,882,0001.31%
Cormorant Asset Management, LP 700,710$15,990,0001.23%
Novo Holdings A/S 750,000$17,115,0000.90%
Artal Group S.A. 400,000$9,128,0000.38%
PFM Health Sciences, LP 369,765$8,438,0000.32%
View complete list of VERVE THERAPEUTICS INC shareholders